Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study.

Takashi Yana; Shunichi Negoro; Minoru Takada; Soichiro Yokota; Yoshiki Takada; Takahiko Sugiura; Hidehiko Yamamoto; Toshiyuki Sawa; Masaaki Kawahara; Nobuyuki Katakami

doi:10.1007/s10637-006-9012-9

Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study.

Identifier:nobleid.org/w1/20260515/385ABFD3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/385ABFD3.svg?ark=w1%2F20260515%2F385ABFD3)](https://nobleid.org/work/w1/20260515/385ABFD3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study.

Identifier:nobleid.org/w1/20260515/385ABFD3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/385ABFD3.svg?ark=w1%2F20260515%2F385ABFD3)](https://nobleid.org/work/w1/20260515/385ABFD3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work